Literature DB >> 19922062

Long term adverse effects related to nucleoside reverse transcriptase inhibitors: clinical impact of mitochondrial toxicity.

Anne Maagaard1, Dag Kvale.   

Abstract

Antiretroviral treatment (ART) has provided excellent clinical efficacy in HIV infection, and individuals treated for HIV might therefore expect normal duration of life. However, this enthusiasm might be moderated by some devastating long-term adverse effects that are frequently observed in HIV-infected individuals, phenomena that may be even more pronounced as the HIV-infected populations become older and therefore perhaps more susceptible to some of these adverse effects. We here review the clinical impact of mitochondrial toxicity giving rise to many of the adverse effects caused by ART.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19922062     DOI: 10.3109/00365540903186181

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  18 in total

Review 1.  Lipodystrophy: pathophysiology and advances in treatment.

Authors:  Christina G Fiorenza; Sharon H Chou; Christos S Mantzoros
Journal:  Nat Rev Endocrinol       Date:  2010-11-16       Impact factor: 43.330

Review 2.  Exploring the pathophysiology behind the more common genetic and acquired lipodystrophies.

Authors:  Tom Nolis
Journal:  J Hum Genet       Date:  2013-10-24       Impact factor: 3.172

3.  Probing the structural and molecular basis of nucleotide selectivity by human mitochondrial DNA polymerase γ.

Authors:  Christal D Sohl; Michal R Szymanski; Andrea C Mislak; Christie K Shumate; Sheida Amiralaei; Raymond F Schinazi; Karen S Anderson; Y Whitney Yin
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-29       Impact factor: 11.205

4.  Structural insights into the recognition of nucleoside reverse transcriptase inhibitors by HIV-1 reverse transcriptase: First crystal structures with reverse transcriptase and the active triphosphate forms of lamivudine and emtricitabine.

Authors:  Nicole Bertoletti; Albert H Chan; Raymond F Schinazi; Y Whitney Yin; Karen S Anderson
Journal:  Protein Sci       Date:  2019-08-06       Impact factor: 6.725

5.  When to start antiretroviral therapy.

Authors:  Frank S Rhame
Journal:  Curr Infect Dis Rep       Date:  2011-02       Impact factor: 3.725

6.  BMS-986001, an HIV nucleoside reverse transcriptase inhibitor, does not degrade mitochondrial DNA in long-term primary cultures of cells isolated from human kidney, muscle, and adipose tissue.

Authors:  Faye Wang; Oliver P Flint
Journal:  Antimicrob Agents Chemother       Date:  2013-09-30       Impact factor: 5.191

7.  NRTI backbone in HIV treatment: will it remain relevant?

Authors:  Randall Tressler; Catherine Godfrey
Journal:  Drugs       Date:  2012-11-12       Impact factor: 9.546

8.  Chronic Binge Alcohol-Induced Dysregulation of Mitochondrial-Related Genes in Skeletal Muscle of Simian Immunodeficiency Virus-Infected Rhesus Macaques at End-Stage Disease.

Authors:  Anthony A Duplanty; Liz Simon; Patricia E Molina
Journal:  Alcohol Alcohol       Date:  2017-05-01       Impact factor: 2.826

9.  Physiologically Relevant Concentrations of Dolutegravir, Emtricitabine, and Efavirenz Induce Distinct Metabolic Alterations in HeLa Epithelial and BV2 Microglial Cells.

Authors:  Joseph W George; Jane E Mattingly; Nashanthea J Roland; Cassandra M Small; Benjamin G Lamberty; Howard S Fox; Kelly L Stauch
Journal:  Front Immunol       Date:  2021-05-20       Impact factor: 7.561

10.  Premature and accelerated aging: HIV or HAART?

Authors:  Reuben L Smith; Richard de Boer; Stanley Brul; Yelena Budovskaya; Hans van Spek
Journal:  Front Genet       Date:  2013-01-28       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.